Ultragenyx Pharma (RARE) Tops Q1 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Ultragenyx Pharma (RARE) PT Raised to $68 at Jefferies; Reiterates Hold
May 8, 2017 7:29 AM EDTJefferies raised its price target on Ultragenyx Pharma (NASDAQ: RARE) to $68.00 (from $66.00) while maintaining a Hold rating. 1Q expenses consisted of $51.3M R&D vs. $48.0M estimates, and $18.7M G&A vs. $20.2M.
Following recently reported ph.III KRN23 results in adult... More

